Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!
5 subscribers
Apr 15 • 88 tweets • 32 min read
1) Welcome to a 🆕 #accredited #tweetorial on #Albuminuria: The Canary in the Coal Mine of #Kidney and #Cardiorenal #Disease. Our returning expert author is the wonderful teacher Edgar V. Lerma 🇵🇭 @edgarvlermamd
#Cardiorenal #Nephpearls #nephtwitter #FOAMed #CardioTwitter 2) The program is intended for #HCPs & is supported by an independent educational grant from Bayer. Statement of accreditation and faculty disclosures at . Follow this 🧵for 0.75hr 🆓 CE/#CMEcredit--all delivered right here on X!cardiometabolic-ce.com/disclosures/
Jan 9 • 42 tweets • 13 min read
1) Welcome to a 🆕#accredited #tweetorial on the challenges clinicians face when managing #venous #thromboembolism in patients with #cancer: cancer-associated thrombosis or #CAT. Our expert faculty is #shematologist Jean Connors MD @connors_md at @BrighamWomens & @DanaFarber.
2a) The program is intended for #healthcare professionals & supported by an independent educational grant from Anthos Therapeutics. Statement of accreditation & faculty disclosures at .cardiometabolic-ce.com/disclosures/
Dec 14, 2023 • 49 tweets • 11 min read
1) Welcome to the next installment of our #MedEd series on the potential for selective inhibitors of coagulation Factor XI or XIa (#FXI/#XIa) for therapeutic anticoagulation. Catch up with us by viewing & earn 🆓CE/#CMEcredit if you haven't already!cardiometabolic-ce.com/antithrombotic…2) That prior program shared and explained the results of the #LBCT data from #AZALEA_TIMI_71 at #AHA23. Lots has happened in the #FXI world since then, so it's time revisit and recap.
Oct 10, 2023 • 32 tweets • 9 min read
1) Welcome to a 🆕#LIVE #accredited #tweetorial posted from #Toronto and #WSC2023, where we have just seen top-line results of #ANNEXa_I, the FIRST randomized comparison between #andexanet_alfa & usual care in pts with anti-#FXa #DOAC-associated #ICH.
2) Our expert author is #ANNEXa_I investigator Ashkan Shoamanesh MD @Ash_Shoamanesh, #Stroke #Neurologist @HamHealthSci, Assoc Prof @McMasterU, & Director of Hemorrhagic Stroke Research Program & Scientist @PHRIresearch #FOAMed #FOAMcc #neurotwitter #cardiotwitter #MedEd
Sep 25, 2023 • 41 tweets • 17 min read
1a) Welcome to a 🆕#accredited tweetorial on Analyzing Safety Data for #siRNA for Lowering #LDL-C and #Lp(a). Our expert faculty is James A. Underberg, MD, MS, FACPM, FACP, MNLA @lipiddoc
#Cardiotwitter #FOAMed
1b) @lipiddoc is a #lipidologist🩺🧬@nyulangone @NYUCVDPrevent. He is President of the Foundation of @nationallipid, Past-President of both @nationallipid AND @LipidBoard, and is Director of @BHLipidClinic. @cardiomet_CE is proud to welcome @lipiddoc as new faculty!
Sep 19, 2023 • 44 tweets • 15 min read
1) Welcome to a 🆕#accredited tweetorial on Recent Advances in the Risk Assessment in Patients with Hyperlipidemia: Enhancing Precision and Reliability. Our expert faculty is Dr Nataliya Pyslar @NP_ltl_a, #Cardiologist& Lipid Specialist @CookCtyHealth.
#Cardiotwitter #FOAMed 2) This presentation was originally delivered by @NP_ltl_a at an accredited satellite symposium at @nationallipid's June 2023 congress. She shared the podium there with lipidology & #preventive #cardiology experts @alanbrownmd, @jpenamd, & @lipiddoc.
@MedTweetorials
Jul 5, 2023 • 41 tweets • 11 min read
1) Welcome to a 🆕#accredited #tweetorial & another opportunity to earn 🆓CE/#CME! Just follow this 🧵as returning expert author Ph.Gabriel Steg @gabrielsteg 🇫🇷 discusses the basics of #HCM along with special considerations for the #interventionalist.
#FOAMed #CardioTwitter https://t.co/zVfX7HWbg0twitter.com/i/web/status/1… 2) This program is intended for #HCPs & is supported by an unrestricted educational grant from Bristol Myers Squibb. Statement of accreditation and faculty disclosures at .
FOLLOW US for expert-authored #cardiometabolic programs for 🆓CE/#CMEcardiometabolic-ce.com/disclosures/
Jun 24, 2023 • 24 tweets • 9 min read
1a) Welcome to a live-tweeted, #accredited #tweetorial from #ADA23 @AmDiabetesAssn in #SanDiego on advances in #hyperlipidemiamanagement #LLT. Our expert returning faculty is Christopher Cannon, MD @cpcannon #cardiologist from @harvardmed & @BrighamWomens.
#CardioTwitter #MedEd
1b) Patients with #diabetes #PWDs are of course at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL. Therefore it's no surprise that a 🌶️topic at #ADA23 would be management of #HL and #CV disease prevention!
#FOAMed @MedTweetorials
1) Welcome to Part 2 of a new #accredited#tweetorial in our series of educational programs on #hypertrophic#cardiomyopathy#HCM. DOn't miss Part 1, still available for 🆓CE/#CME, at cardiometabolic-ce.com/hcm5a/.
Now you can learn more, and EARN MORE credit, by following this 🧵!
2) Our expert author is again Sergio Kaiser MD PhD FACC FESC 🇧🇷🇮🇱 @pabeda1, cardiologist 🫀, Professor 🎓 of #InternalMedicine, Rio de Janeiro State University. He brings the general cardiologist's perspective to our #HCM discussions. Read and learn! #FOAMed#CardioTwitter
1a) Welcome to a new #accredited#tweetorial on the management of aFXa-DOAC-associated #hemorrhage and specifically the role of coag laboratory testing in these challenging cases.
1b) Our expert author is #pharmacist Craig Beavers, PharmD @beaverspharmd CV Clinical Pharmacy Specialist @UK_COP, and Immediate Past Chair of the @ACCinTouch#ACCCVT Section
Join us tomorrow for the launch of a new #accredited#tweetorial on the primary care management of #hyperlipidemia covering the relationship between #LDL_C & major #CV events, CV risk categories, recommended LDL-C treatment goals, & oral therapeutic options for lipid-lowering
1) Welcome to a new #tweetorial on the primary care management of #hyperlipidemia. Our returning @cardiomet_CE expert author is dedicated #SoMe education advocate Kevin Fernando, FRCGP FRCP Edin, FAcadMEd MSc Diabetes @drkevinfernando